Is complement the culprit behind COVID-19 vaccine-related adverse reactions?
作者信息
Mastellos Dimitrios C, Skendros Panagiotis, Lambris John D
机构信息
National Center for Scientific Research 'Demokritos', Athens, Greece.
First Department of Internal Medicine and Laboratory of Molecular Hematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
出版信息
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI151092.
Abstract
摘要
相似文献
1
Is complement the culprit behind COVID-19 vaccine-related adverse reactions?补体是新冠疫苗相关不良反应的罪魁祸首吗？
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI151092.
2
Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.新型冠状病毒时代的补体介导溶血性贫血：病例系列及文献复习。
Front Immunol. 2021 Nov 25;12:791429. doi: 10.3389/fimmu.2021.791429. eCollection 2021.
3
COVID-19 vaccines for patients with haematological conditions.用于血液系统疾病患者的新冠疫苗。
Lancet Haematol. 2021 May;8(5):e312-e314. doi: 10.1016/S2352-3026(21)00073-9. Epub 2021 Mar 31.
4
Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.一名22岁接种新冠疫苗后出现的免疫性血小板减少症。
Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021 Feb 11.
5
Safety of mRNA-Based Vaccines for SARS CoV-2.mRNA 疫苗在 SARS-CoV-2 中的安全性。
Chem Res Toxicol. 2021 Aug 16;34(8):1823-1825. doi: 10.1021/acs.chemrestox.1c00129. Epub 2021 May 19.
6
Vaccine against SARS-CoV-2 in previously infected health care workers.曾感染过新冠病毒的医护人员接种新冠病毒疫苗。
EBioMedicine. 2021 Sep;71:103556. doi: 10.1016/j.ebiom.2021.103556. Epub 2021 Aug 26.
7
Mounting evidence suggests Sputnik COVID vaccine is safe and effective.越来越多的证据表明，卫星V新冠疫苗是安全有效的。
Nature. 2021 Jul;595(7867):339-340. doi: 10.1038/d41586-021-01813-2.
8
The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.mRNA疫苗的世纪：新冠疫苗与过敏
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.
9
SARS-CoV-2 infection confers greater immunity than shots.感染新冠病毒所产生的免疫力强于接种疫苗。
Science. 2021 Sep 3;373(6559):1067-1068. doi: 10.1126/science.acx8993. Epub 2021 Sep 1.
10
Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.实现全球公平分配 COVID-19 疫苗：需要加强国际伙伴关系，增强宣传和团结。
PLoS Med. 2021 Sep 13;18(9):e1003772. doi: 10.1371/journal.pmed.1003772. eCollection 2021 Sep.
引用本文的文献
1
Global Burden of Vaccine-Associated Cerebrovascular Venous Sinus Thrombosis, 1968-2024: A Critical Analysis From the WHO Global Pharmacovigilance Database.1968 - 2024年疫苗相关脑血管静脉窦血栓形成的全球负担：来自世界卫生组织全球药物警戒数据库的批判性分析
J Korean Med Sci. 2025 Mar 24;40(11):e101. doi: 10.3346/jkms.2025.40.e101.
2
Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia.内皮细胞活化增强疫苗诱导的免疫性血栓性血小板减少症中的血栓炎症反应。
Blood Adv. 2025 Jun 24;9(12):2891-2906. doi: 10.1182/bloodadvances.2024014165.
3
Proteomic signatures of vaccine-induced and breakthrough infection-induced host responses to SARS-CoV-2.疫苗诱导和突破性感染诱导的宿主对SARS-CoV-2反应的蛋白质组学特征
Vaccine. 2025 Jan 1;43(Pt 1):126484. doi: 10.1016/j.vaccine.2024.126484. Epub 2024 Nov 8.
4
New Onset of Neuro-Sjögren's Syndrome Nine Months After the Third COVID-19 Vaccine Dose: A Case Report.第三次接种新冠疫苗九个月后新发神经干燥综合征：一例报告
Cureus. 2024 Sep 16;16(9):e69562. doi: 10.7759/cureus.69562. eCollection 2024 Sep.
5
Development and Challenges of Cyclic Peptides for Immunomodulation.环状肽在免疫调节中的发展与挑战。
Curr Protein Pept Sci. 2024;25(5):353-375. doi: 10.2174/0113892037272528231030074158.
6
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know.补体与 COVID-19：三年过去了，我们知道了什么，不知道什么，以及我们应该知道什么。
Immunobiology. 2023 May;228(3):152393. doi: 10.1016/j.imbio.2023.152393. Epub 2023 May 11.
7
Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.回应：评论：与新冠疫苗相关的大疱性类天疱疮：一项意大利多中心研究。
Front Med (Lausanne). 2023 Mar 16;10:1160672. doi: 10.3389/fmed.2023.1160672. eCollection 2023.
8
Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature.Co-VAN 研究：COVID-19 疫苗相关神经系统疾病——来自顶尖神经科学中心的经验及文献复习。
J Clin Neurosci. 2023 Feb;108:37-75. doi: 10.1016/j.jocn.2022.12.015. Epub 2022 Dec 23.
9
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.辉瑞-生物科技（BNT162b2）、莫德纳（mRNA-1273）COVID-19 mRNA 疫苗与过敏反应。
J Natl Med Assoc. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. Epub 2022 Oct 28.
10
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review.垂体卒中与 COVID-19 疫苗接种：病例报告及文献复习。
Front Endocrinol (Lausanne). 2022 Nov 17;13:1035482. doi: 10.3389/fendo.2022.1035482. eCollection 2022.
本文引用的文献
1
Prothrombotic immune thrombocytopenia after COVID-19 vaccination.接种 COVID-19 疫苗后的促血栓形成免疫性血小板减少症。
Blood. 2021 Jul 29;138(4):350-353. doi: 10.1182/blood.2021011958.
2
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.接种 ChAdOx1 nCoV-19 疫苗后对血小板因子 4 的病理性抗体。
N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16.
3
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.Ad26.COV2.S疫苗接种后血栓性血小板减少症
N Engl J Med. 2021 May 20;384(20):1964-1965. doi: 10.1056/NEJMc2105869. Epub 2021 Apr 14.
4
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
5
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.佩格司他单抗与依库珠单抗治疗阵发性睡眠性血红蛋白尿症的疗效比较。
N Engl J Med. 2021 Mar 18;384(11):1028-1037. doi: 10.1056/NEJMoa2029073.
6
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.mRNA-1273 疫苗中 COVID-19 的过敏原成分：可能涉及聚乙二醇和 IgG 介导的补体激活。
Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun 17.
7
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.肝素诱导的血小板减少症：发病机制、诊断及管理新概念综述
J Clin Med. 2021 Feb 10;10(4):683. doi: 10.3390/jcm10040683.
8
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
9
Adenovirus-Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes.腺病毒-细胞外蛋白相互作用及其对人单核吞噬细胞固有免疫应答的影响。
Viruses. 2020 Nov 26;12(12):1351. doi: 10.3390/v12121351.
10
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy.补体 C3 与 C5 抑制在重症 COVID-19 中的作用：早期临床发现揭示了不同的生物学疗效。
Clin Immunol. 2020 Nov;220:108598. doi: 10.1016/j.clim.2020.108598. Epub 2020 Sep 19.
Zotero 插件